Latest News and Updates
Precision BioSciences Raises $110M to Advance ARCUS Genome Editing Programs
DURHAM, North Carolina, USA, June 26 2018 –Precision BioSciences today announced the closing of an oversubscribed $110M Series B financing to further product development efforts based on its ARCUS® genome editing platform. The financing was led by ArrowMark Partners...
Hemi Zucker to Join OCV Management as Managing Principal
LOS ANGELES – OCV Management LLC (“OCV”), a technology investor based in Los Angeles, announced today that Nehemia (“Hemi”) Zucker will be joining the firm as Managing Principal starting on January 1, 2018. Until such date, Hemi will continue as CEO of j2 Global Inc....
With our decades of company building experience, we look to create asymmetric advantages when backing winning teams.